TP53 and adenocarcinoma: Survival analysis indicated that FIGO stage III/IV, GAC, or the non‐HPV‐related adenocarcinomas, LVI, PNI, and p53 overexpression were associated with poor disease‐specific survival in cervical adenocarcinomas (p < 0.05) (Figure 3).